Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

rhinocerous biobank

News and Trends 19 Feb 2019

From Saving Endangered Rhinos to Enabling Lab-Grown Meat

Researchers at the University of Oslo are building a biobank of animal cells, the first of its kind, to help researchers develop lab-grown meat and contribute to the conservation of endangered species. Gareth Sullivan became familiar with stem cell technology while working in the group of Ian Wilmut, the scientist behind cloning Dolly the sheep. […]

February 19, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

acne s biomedic skinbiotherapeutics skin microbiome

News and Trends 19 Feb 2019

Skin Microbiome Biotechs Get Funding Boost

Two major skin microbiome companies have received investments this week: the Belgian company S-Biomedic, which is developing a probiotic acne treatment, and the UK biotech SkinBioTherapeutics, which is targeting eczema. A lot of attention goes to the gut microbiome when talking about probiotic disease treatments, but skin bacteria may also have potential, as these […]

February 19, 2019 - 2 minutesmins - By Jonathan Smith

Gut bacteria

In Depth 19 Feb 2019

How New Microbiome Diagnostic Technologies Can Save Lives

With the rise of a whole new field of research around the microbiome, what role are new technologies to identify microorganisms playing in the future of healthcare? Traditionally, microbes have been seen solely as a threat. But in the last few years, microbiome research has started to shift this view. Today, we know certain microorganisms […]

February 19, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

tuberculosis suicide cnrs embl Francis Crick antibiotic resistance immune

News and Trends 18 Feb 2019

Tuberculosis Treatment Kills Bacteria with Their Own Suicide Toxin

A European academic research collaboration has found a new potential weapon against antibiotic-resistant tuberculosis: its own toxins. Many types of bacteria, such as the pathogen responsible for the deadly lung disease tuberculosis, Mycobacterium tuberculosis, use toxins to stay alive. For example, these toxins can be useful when the bacteria are starved or infected by viruses, […]

February 18, 2019 - 3 minutesmins - By Jonathan Smith

arvelle therapeutics SK Biopharmaceuticals Axovant epilepsy

More News! 18 Feb 2019

Enormous Series A to Help Bring Epilepsy Drug to Market

One of the biggest Series A rounds in European biotech, €159M ($180M), has been raised by the Swiss company Arvelle Therapeutics to help commercialize its epilepsy drug. Formed just this month, Arvelle plans to submit an application for EMA approval for the small molecule drug cenobamate, which it has licensed from the South Korean company […]

February 18, 2019 - 2 minutesmins - By Jonathan Smith

top genomic companies cover 1140x418

Best in Biotech 18 Feb 2019

10 European Genomics Companies to Watch Out For

Next generation sequencing has revolutionized the biotech industry and genomics technology has changed dramatically over the last few years. There are many interesting European genomics companies, but here are 10 we thought especially worthy of mention. By 2025, the size of global genomics market is predicted to reach a whopping €24B, and unsurprisingly, there’s a […]

February 18, 2019 - 8 minutesmins - By David Cox

ADVERTISEMENT

medical university of vienna kidney transplant genomics

News and Trends 15 Feb 2019

Genetic Testing Improves Success of Kidney Transplants

Genetic variations in cell surface proteins are able to predict kidney transplant success, shows Austrian research, serving as a potential screening tool for improving future transplants. Many kidney transplants fail over time because the patient’s immune system rejects the organ. This rejection happens because the immune system recognizes that particular proteins on the cell surface, such […]

February 15, 2019 - 2 minutesmins - By Jonathan Smith

biomillenia microbiome lab on a chip workflow paris scene

Startup Scout 15 Feb 2019

This Lab-on-a-Chip Can Screen Millions of Bacteria in Parallel

Our French biotech of the week, Biomillenia, is developing a lab-on-a-chip that can screen millions of strains of bacteria in a fraction of the time it takes for traditional methods. This technology can identify previously unculturable strains for use in agriculture, animal health, or microbiome-based therapies. Mission: To use lab-on-a-chip technology to culture and screen […]

February 15, 2019 - 4 minutesmins - By Jonathan Smith

london biotech hub medcity british library

More News! 14 Feb 2019

London’s Biotech Ecosystem Boosted with €900M Expansion

The British Library has greenlit the construction of a new research hub on its property in North London, increasing the business potential for the biotech ecosystem in the southeast of England. The new site, costing up to €900M (£800M), will expand premises held by the British Library, which is next to King’s Cross and the […]

February 14, 2019 - 3 minutesmins - By Jonathan Smith

type 2 diabetes treatment poxel2 1

News and Trends 14 Feb 2019

Hair Loss Biotech Ventures into Diabetes Market

The Swedish biotech Follicum has added drugs for type 2 diabetes into its pipeline, which focuses on treatments for hair loss. The market for type 2 diabetes treatments is huge, and competitive. While many approved treatments help to control blood sugar in type 2 diabetes, fluctuating blood sugar levels can damage vital insulin-producing beta cells. Many diabetics […]

February 14, 2019 - 3 minutesmins - By Jonathan Smith

new website cover 1213x418

Inside Labiotech 14 Feb 2019

Say Hello to The Brand-New Labiotech.eu, Our Biggest Product Redesign Since We Launched 💥

You might have noticed that something changed on our site today. Indeed, we’re very proud to launch our brand-new website, which we started from scratch on a blank piece of paper. We are further improving your user experience and the page performance, and we’ll have the possibility of adding more crazy features in the coming […]

February 14, 2019 - 4 minutesmins - By Philip Hemme

biotech risk success

Interview 13 Feb 2019

Embracing Risk to Succeed in Biotech

Biotech can be a very risky business, but embracing the risk can be the key to success. At our last Labiotech Refresh in Heidelberg, we got to talk to Friedrich von Bohlen, scientist, entrepreneur and investor, about how he approaches risk and what he thinks about the future of biotech. Friedrich von Bohlen is the […]

February 13, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT